Ask AI
ProCE Banner Activity

Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?

Slideset Download
Download this brief slideset for an update on biomarkers to guide treatment of patients with ES-SCLC with immunotherapy.

Released: February 01, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Benjamin Levy, MD, FASCO

Associate Professor
Johns Hopkins School of Medicine
Clinical Director of The Sidney Kimmel Cancer Center
Johns Hopkins Medicine at Sibley Hospital
Washington, DC